J B Chemicals and Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis

JBCHEPHARM Pharmaceuticals
Share Price NSE
₹1942.50
▼ -19.40 (-0.99%)
2026-04-08 00:00:00
Share Price BSE
₹1945.40
▼ -15.60 (-0.80%)
2026-04-08 00:00:00
Track J B Chemicals and Pharmaceuticals share price live with TickJournal's free stock screener. Analyze J B Chemicals and Pharmaceuticals share price history trends and compare 52-week high low levels. Record your trades in TickJournal's free trading journal and track your portfolio performance.
J B Chemicals and Pharmaceuticals Market Cap ₹31,487.17 Cr.
JBCHEPHARM P/E Ratio (TTM) 42.82
J B Chemicals and Pharmaceuticals P/B Ratio 8.48
EPS (TTM) ₹42.45
Dividend Yield 0.75%
Debt to Equity 0.06
JBCHEPHARM 52 Week High ₹2138.60
J B Chemicals and Pharmaceuticals 52 Week Low ₹1504.40
Operating Margin 24.00%
Profit Margin 15.15%
JBCHEPHARM Revenue (TTM) ₹964.00
EBITDA ₹241.00
Net Income ₹146.00
Total Assets ₹4,274.00
Total Equity ₹3,433.00

J B Chemicals and Pharmaceuticals Share Price History - Stock Screener Chart

Screen JBCHEPHARM historical share price movements with interactive charts. Analyze price trends and patterns.

J B Chemicals and Pharmaceuticals Company Profile - Fundamental Screener

Screen J B Chemicals and Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JBCHEPHARM shares.
J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
Chairperson/CEO Arun Duggal
ISIN INE572A01036

J B Chemicals and Pharmaceuticals Balance Sheet Screener

Screen JBCHEPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 4,274 3,994 3,554 2,607 2,238 1,821 1,792 1,765 1,674 1,648
Current Assets 1,923 1,853 1,528 1,253 1,553 1,073 1,051 1,047 795 816
Fixed Assets 1,968 2,004 1,901 1,277 634 651 621 640 679 440
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 208 203 519 85 79 69 65 46 27 31
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 3,433 2,923 2,480 2,139 1,813 1,438 1,483 1,444 1,366 1,186
Share Capital 16 16 16 16 16 16 16 17 17 17
Reserves & Surplus 3,418 2,908 2,465 2,119 1,794 1,420 1,464 1,425 1,347 1,167

J B Chemicals and Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Screen J B Chemicals and Pharmaceuticals income statement and profit fundamentals. Analyze JBCHEPHARM quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for J B Chemicals and Pharmaceuticals share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 964 1,109 1,100 1,083 878 1,010 1,011 972 767 902 889 852 627 786 811
Expenses 723 793 775 769 664 724 730 709 599 664 638 621 500 612 625
EBITDA 241 315 325 314 215 286 281 263 168 238 251 231 127 174 186
Operating Profit % 24.00% 28.00% 29.00% 28.00% 23.00% 28.00% 27.00% 26.00% 21.00% 26.00% 28.00% 26.00% 20.00% 22.00% 23.00%
Depreciation 46 43 44 45 41 41 42 42 32 31 32 34 22 26 28
Interest 2 1 1 2 9 6 2 3 14 12 10 13 2 6 8
Profit Before Tax 193 272 279 267 165 240 237 218 123 194 209 184 103 142 150
Tax 47 69 71 69 38 63 62 56 35 52 58 50 18 37 39
Net Profit 146 202 208 198 126 177 175 163 88 142 151 134 85 105 111
EPS 9.36 12.99 13.29 12.63 8.22 11.39 11.24 10.46 11.33 9.20 9.72 8.62 10.98 13.59 14.37

J B Chemicals and Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen JBCHEPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 903 801 626 170 315 276 194 123 201 140
Investing Activities -296 -404 -962 2 -231 24 -28 -21 -45 -26
Financing Activities -580 -386 357 -138 -87 -306 -156 -60 -184 -100
Net Cash Flow 27 11 20 34 -3 -6 11 43 -28 15

J B Chemicals and Pharmaceuticals Shareholding Pattern Screener

See J B Chemicals and Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check J B Chemicals and Pharmaceuticals promoter holding and ownership changes for JBCHEPHARM on TickJournal.
Item 2026-Jan 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun
Promoter Holding 48.78% 47.55% 47.56% 47.73% 47.84% 53.66% 53.74% 53.77%
FII Holding 14.56% 14.88% 15.30% 17.77% 18.30% 14.64% 13.63% 12.17%
DII Holding 22.71% 23.36% 22.83% 19.63% 18.72% 16.41% 16.81% 17.62%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00%
Public Holding 12.03% 12.37% 12.47% 13.04% 13.28% 13.42% 13.87% 14.38%
Other Holding 1.92% 1.85% 1.84% 1.83% 1.86% 1.87% 1.94% 2.05%
Shareholder Count 68,966 69,338 71,957 70,064 63,948 62,081 62,743 66,953

J B Chemicals and Pharmaceuticals Share Dividend Screener - Share Yield Analysis

Check J B Chemicals and Pharmaceuticals dividend history with payout and yield data. View J B Chemicals and Pharmaceuticals dividend details including ex-dates and amounts for JBCHEPHARM stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹15.50 0.75%
2024-March ₹12.25 0.75%
2023-March ₹17.75 1.08%
2022-March ₹16.50 1.67%
2021-March ₹16.50 2.10%
2020-March ₹11.00 1.75%
2019-March ₹5.00 1.96%
2018-March ₹2.00 1.10%
2017-March ₹1.00 0.64%

J B Chemicals and Pharmaceuticals Stock Index Membership

See which indices include J B Chemicals and Pharmaceuticals stock. Check JBCHEPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MNC
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

J B Chemicals and Pharmaceuticals Market Events Screener - Corporate Actions

Get J B Chemicals and Pharmaceuticals corporate actions including splits, bonuses, and buybacks. Check J B Chemicals and Pharmaceuticals stock events that may affect JBCHEPHARM share price.
Announcement Date Record Date Event Type Information Price Impact
2023-05-24 Split 1:2 0.00%
Dividend ₹ 8.00 /share 10.40%
2026-02-11 2026-02-11 Dividend ₹ 12.70 /share 1.60%
2026-01-16 2026-01-16 Quarterly Result Announcement NA 4.16%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 6.12%
2025-08-06 2025-08-06 Annual General Meeting NA 4.95%
2025-07-30 2025-07-30 Dividend ₹ 7.00 /share 14.10%
2025-07-30 2025-07-30 Quarterly Result Announcement NA 9.13%
2025-05-14 2025-05-14 Quarterly Result Announcement NA -4.75%
2025-02-07 2025-02-08 Dividend ₹ 8.50 /share -2.35%
2025-02-04 2025-02-04 Quarterly Result Announcement NA -5.04%
2024-11-06 2024-11-06 Quarterly Result Announcement NA -2.31%
2024-08-21 2024-08-21 Annual General Meeting NA 8.60%
2024-08-14 2024-08-14 Dividend ₹ 6.75 /share 5.95%
2024-02-16 2024-02-16 Dividend ₹ 5.50 /share -2.58%

J B Chemicals and Pharmaceuticals Competitors Screener - Peer Comparison

Screen JBCHEPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 406,351 37.86 54,729 9.71% 10,980 37.98
Divis Laboratories 155,472 63.26 9,712 18.67% 2,191 33.24
Torrent Pharmaceuticals 134,945 61.20 11,539 6.99% 1,911 32.75
Lupin 103,954 22.26 22,910 13.74% 3,306 47.35
Dr Reddys Laboratories 101,601 18.27 33,741 16.73% 5,725 39.36
Cipla 96,320 21.31 28,410 7.12% 5,291 26.86
Zydus Life Science 86,964 17.29 23,511 18.55% 4,615 41.42
Mankind Pharma 82,499 45.81 12,744 20.90% 2,007 41.40
Aurobindo Pharma 77,462 22.37 32,346 9.43% 3,484 64.38
Alkem Laboratories 62,867 25.87 13,458 3.70% 2,216 42.54

J B Chemicals and Pharmaceuticals Company Announcements - News Screener

Screen JBCHEPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-07 Announcement under Regulation 30 (LODR)-Cessation -
2026-04-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-04-02 Closure of Trading Window -
2026-04-02 Notice For NCLT Convened Meeting Of Equity Shareholders -
2026-03-31 Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-03-30 Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-03-30 Appointment Of Directors -
2026-03-30 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-03-30 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-03-19 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-03-13 Announcement under Regulation 30 (LODR)-Change in Management -
2026-03-11 Announcement under Regulation 30 (LODR)-Cessation -
2026-03-10 Announcement under Regulation 30 (LODR)-Cessation -
2026-02-23 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-20 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-02-19 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-02-07 Announcement under Regulation 30 (LODR)-Cessation -
2026-02-05 Announcement under Regulation 30 (LODR)-Cessation -
2026-02-05 Intimation Of Record Date -
2026-02-05 Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors -